Owner Drugtech Corporation

Inventors Hermelin, Marc S.; Levinson, R. Saul; Kirschner, Mitchell I.

Agent FB Rice

Pub. Number AU-B-2005200907

Parent 778507

Filing date 28 February 2005

Wipo publication date 7 April 2005

Acceptance publication date 15 March 2007

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A23L 1/30 (2006.01) Foods or foodstuffs - containing additives

A23L 1/302 (2006.01) Foods or foodstuffs - Vitamins

A23L 1/304 (2006.01) Foods or foodstuffs - Inorganic salts, minerals, trace elements

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/07 (2006.01)

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/194 (2006.01)

A61K 31/198 (2006.01)

A61K 31/201 (2006.01)

A61K 31/202 (2006.01)

A61K 31/355 (2006.01)

A61K 31/375 (2006.01) - Ascorbic acid, i.e. vitamin C

A61K 31/4168 (2006.01)

A61K 31/4415 (2006.01) - Pyridoxine, i.e.vitamin B

A61K 31/51 (2006.01)

A61K 31/525 (2006.01)

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/566 (2006.01) - having an oxo group in position 17, e.g. oestrone

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone